Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells

Cancer Chemotherapy and Pharmacology
David SadavaSusan E Kane

Abstract

We examined the pharmacology, cell biology and molecular biology of small-cell lung carcinoma cells treated with four extracts of Chinese herbal medicines. Many cancer patients take these medicines, but their effects at the cellular level are largely unknown. We were especially interested in the effects on drug-resistant cells, as resistance is a significant clinical problem in lung cancer. Drug-sensitive (H69), multidrug-resistant (H69VP) and normal lung epithelial cells (BEAS-2) were exposed to extracts from two plants used in Chinese herbal medicine for lung cancer: Glycorrhiza glabra (GLYC) and Olenandria diffusa (OLEN), and to extracts of two commercially available combinations of Chinese herbal medicines, SPES (15 herbs) and PC-SPES (8 herbs). Cytotoxicity was measured in terms of cell growth inhibition (IC(50)). The kinetics of DNA fragmentation after exposure to the herbal extracts was measured by BudR labeling followed by ELISA. Apoptosis was measured by the TUNEL assay followed by flow cytometry. Expression of apoptosis- and cell cycle-related genes was measured by reverse transcription of mRNA followed by filter hybridization to arrays of probes and detection by chemiluminescence. In each case, the four herbal extrac...Continue Reading

Citations

Dec 25, 2004·Analytical and Bioanalytical Chemistry·Zhong-Da ZengCheng-Jian Xu
Nov 29, 2005·Molecular and Cellular Biochemistry·Rama S RangaDamodaran Chendil
May 4, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Andy SunWon-Bo Wang
Jan 7, 2005·Biological & Pharmaceutical Bulletin·Kohji TakaraTeruyoshi Yokoyama
Jun 7, 2012·Current Oncology·M GrossmanG Batist
Feb 11, 2011·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·L YangL-Y Kong
Oct 16, 2007·Journal of Ethnopharmacology·Shaun WillimottElizabeth I Opara
Jun 26, 2007·Biochemical and Biophysical Research Communications·David SadavaSusan E Kane
Jan 18, 2005·Journal of Ethnopharmacology·Huey-Lan HuangRay-Ling Huang
Aug 26, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Luara de Sousa MonteiroMarianna Vieira Sobral
Jul 25, 2013·Cancer Letters·David Sadava, Susan E Kane
Feb 4, 2010·The American Journal of Chinese Medicine·Jian-Hui TianLin Wang
Mar 17, 2017·International Journal of Molecular Sciences·Lovro ŽibernaSeyed Mohammad Nabavi
Dec 12, 2003·Integrative Cancer Therapies·Geoffrey A Cordell
Jun 27, 2009·Immunopharmacology and Immunotoxicology·Mohammad Lalmoddin MollahKil-Soo Kim
Apr 6, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Xinkui LiuXiaomeng Zhang
Feb 21, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bowen YangZhiyu Wang
Mar 3, 2005·Journal of Agricultural and Food Chemistry·Huey-Lan HuangYu-Jen Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.